Astrana Health Inc. is a physician-centric, technology-powered, risk-bearing healthcare company that operates an integrated healthcare delivery platform to enable providers to participate in value-based care arrangements. The company organizes independent providers into risk-bearing organizations, including independent practice associations, accountable care organizations, and Restricted Knox-Keene licensed health plans, to manage total cost of care across Medicare, Medicaid, commercial, and exchange insurance lines. Its business is divided into three segments: Care Partners, which builds and manages provider networks; Care Delivery, which operates primary care clinics, specialty care facilities, and ancillary services such as urgent care, imaging, and ambulatory surgery; and Care Enablement, which provides a proprietary technology suite and management services for population health management and care coordination. The company serves patients covered by private or public insurance and partners with health plans, hospitals, and independent physician groups. Formerly known as ApolloMed and Network Medical Management, the company rebranded to Astrana Health in February 2024.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Healthcare Plans Homepage astranahealth.com
Sector Healthcare IR page ir.astranahealth.com
Tags
value-based care, population health management, care coordination, independent practice associations, accountable care organizations, restricted knox-keene plans, primary care, specialty care, urgent care, ambulatory surgery, outpatient imaging, hospitalist services, ApolloMed, Network Medical Management
Press page ir.astranahealth.com/news-events/press-releases

Metrics

Valuation  
Market cap $ 1.754B
Market cap (USD) $ 1.754B
P/E 33.24
PEG —
P/BV 2.05
P/S 0.45
P/OCF 15.31
P/FCF 16.79
Dividend yield 0.03%
Turnover / mcap —
Returns  
ROE 3.0%
ROI 1.2%
ROIC 2.6%
Profit margin 0.71%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) -22.9%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity 108.0%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 24
Quality score 0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2008 FY 2007
Revenue 3.182B 2.035B 1.387B 1.144B 773.915M 687.18M 560.618M 519.908M 357.747M 44.049M 32.99M 10.484M 7.776M 5.111M 3.897M 1.057M 90.5K
Net profit 22.487M 43.149M 60.717M 49.049M 73.858M 37.866M 14.117M 10.835M 25.802M -9.344M -1.803M -4.559M -8.905M -720.346K -156.331K -891.815K -154.462K
Free cash flow 104.491M 44.167M 39.698M 59.188M 51.112M 44.999M 12.632M 24.326M 49.845M -2.101M -316.419K -1.501M 12.157K -392.66K -266.196K — —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2008 FY 2007
Share price 24.81 31.53 38.3 29.59 73.48 18.27 18.41 19.85 23.97 — — — — — — — —
Price performance 12m -0.21 -0.18 0.29 -0.6 3.02 -0.01 -0.07 -0.17 — — — — — — — — —

Filed figures

Figure Mar 2017 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 5.51M 20.1M 7.73M 11M 7.06M 10.6M 52.6M — 276M 374M
↳ YoY growth +62.3% +236.1% -61.6% +42.3% -35.9% +50.3% +396.1% +35.7%
↳ 5y CAGR +25.7% +14.1% +12.1% +21.2% +90.5% +121.3%
Borrowings, current (USD) 9.9M — 0.00 9.5M 10.9M 780,000 619,000 19.5M 9.38M 47.9M
Borrowings, non-current (USD) — — 0.00 232M 230M 183M 203M 259M 425M 991M
Lease liabilities (USD) — — 619,002 14.9M 19.5M 17.3M 25.4M 42.6M 37.2M 39.4M
Cash and deposits (USD) 8.66M 99.7M 107M 103M 193M 233M 288M 294M 288M 429M
Intangible assets (USD) 1.9M 104M 86.9M 103M 87M 82.8M 76.9M 71.6M 118M 271M
Right-of-use assets (USD) — — 0.00 14.2M 18.6M 15.4M 20.4M 37.4M 32.6M 35.7M
Net debt (borrowings + leases - cash) (USD) 1.24M — -106M 153M 67.1M -32.1M -58.7M 27.2M 183M 649M
Cash flow detail
Operating cash flow (USD) -8.14M 51.9M 25.5M 13.7M 46.2M 70.3M 82.1M 68.2M 52.2M 115M
Purchases of property, plant and equipment (USD) -297,561 -2.08M -1.17M -1.04M -1.16M -19.2M -22.9M -28.5M -8.03M -10.1M
Change in receivables (cash effect) (USD) -2.78M 10.7M -263,191 10.7M 4.13M -1.52M -41.2M -26.7M -44.4M -9.42M
Change in payables (cash effect) (USD) 3.65M -3.69M -22.7M -4.88M 8.2M 3.22M -49,000 -170,000 -30.9M -6.99M
Dividends paid (cash effect) (USD) — -10.4M -17.8M -61.7M -51.3M -31.1M -14M -62.1M -4.04M -7.89M
Share buybacks (cash effect) (USD) — -3.18M -5.05M -7.57M -537,000 -5.74M -9.25M -10.2M -900,000 -25.6M
Interest paid (cash effect) (USD) -23,532 -51,043 -462,336 -4.26M -8.51M -4.16M -6.67M -14.3M -30.4M -45.8M
Income taxes paid (cash effect) (USD) -30,902 -24.4M -23.6M -20.2M -62M -37.2M -47.3M -56.6M -43.9M —
Share-based compensation (USD) 1.11M 2.74M 1.44M 1.55M 3.38M 6.75M 16.1M 22M 34.5M 38.6M
Operating cash flow before change in receivables (USD) -5.36M 41.2M 25.8M 2.96M 42M 71.9M 123M 95M 96.6M 124M
Free cash flow (OCF - PPE - intangibles) (USD) -8.44M 49.8M 24.3M 12.6M 45M 51.1M 59.2M 39.7M 44.2M 104M
Income detail
Provision for credit losses (USD) 385,597 0.00 3.89M -1.36M 0.00 0.00 — — — —
Credit cost ratio (credit losses / average receivables) (%) 8.7% 0.0% 27.9% 14.6% 0.0% 0.0% — — — —
Reported Jun 29, 2017 Mar 18, 2019 Mar 16, 2020 Mar 16, 2020 Mar 15, 2021 Feb 28, 2022 Mar 1, 2023 Feb 29, 2024 Aug 7, 2025 Mar 12, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

November 05, 2026 4:05pm EST Download as PDF

Related Documents

Earnings Webcast Audio

Presentation PDF

10-Q HTML PDF

XBRL ZIP

Company to Host Conference Call on Thursday, November 5, 2026, at 2:30 p.m. PT/5:30 p.m. ET

  • Reports record revenue of $1,023.6 million, up 7% year-over-year, net income of $20.3 million, up 1,782% year-over-year, and record adjusted EBITDA_(1)_ of $77.2 million, up 13% year-over-year for the three months ended September 30, 2026
  • Reports net cash provided by operating activities of $117.1 million and free cash flow_(2)_ of $105.4 million for the nine months ended September 30, 2026

ALHAMBRA, Calif., Nov. 5, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the third quarter ended September 30, 2026.

Astrana Health

"Our third quarter results demonstrate the growing impact of Astrana's physician-centric, AI-native healthcare operating platform and our team's continued focus on execution," said Brandon Sim, President and Chief Executive Officer of Astrana Health. "We delivered record revenue, record adjusted EBITDA, and double-digit organic earnings growth while continuing to invest in the next phase of our growth. By combining proprietary technology, aligned physician partnerships, and integrated care delivery, we're building a scalable, repeatable model to improve patient outcomes and manage the total cost of care – a value proposition that extends across payer and reimbursement models and positions us to create sustainable long-term value for patients, physician partners, and shareholders."

Financial Highlights for Third Quarter Ended September 30, 2026:

All comparisons are to the three months ended September 30, 2025 unless otherwise stated.

  • Total revenue of $1,023.6 million, up 7% from $956.0 million
  • Care Partners revenue of $968.8 million, up 8% from $897.7 million
  • Net income attributable to Astrana of $13.0 million, up from $0.4 million
  • Earnings per share ("EPS") - diluted of $0.26, up from $0.01
  • Adjusted EBITDA(1) of $77.2 million, up 13% from $68.5 million
  • Adjusted EPS - diluted(3) of $0.71, up 4% from $0.68

Financial Highlights for Nine Months Ended September 30, 2026:

All comparisons are to the nine months ended September 30, 2025 unless otherwise stated.

  • Total revenue of $2,961.2 million, up 33% from $2,231.2 million
  • Care Partners revenue of $2,811.3 million, up 32% from $2,130.1 million
  • Net income attributable to Astrana of $47.1 million, up 186% from $16.5 million
  • EPS - diluted of $0.95, up 188% from $0.33
  • Adjusted EBITDA(1) of $212.4 million, up 39% from $153.0 million
  • Adjusted EPS - diluted(3) of $2.25, up 36% from $1.66
  • Net cash provided by operating activities of $117.1 million
  • Free cash flow(2) of $105.4 million
(1) See "Reconciliation of Net Income to EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin" and "Use of Non-GAAP Financial Measures" below for additional information.
(2) See reconciliation provided with the condensed consolidated statements of cash flows and "Use of Non-GAAP Financial Measures" below for additional information.
(3) See "Reconciliation of Net Income to Adjusted Net Income Attributable to Astrana and Adjusted EPS - Diluted" and "Use of Non-GAAP Financial Measures" below for additional information.

Recent Operating Highlights

  • Closed the acquisition of an independent practice association in Georgia on October 1, 2026.
  • Added two Care Enablement clients, a provider group in Connecticut and a hospital in California, with both expected to onboard onto Astrana's AI-powered technology and managed services platform in early 2027.
  • Entered into several new Medicare Advantage payer partnerships effective January 1, 2027, with new health plan partners in markets including Southern California, Texas, and Arizona, supporting continued membership growth across the Astrana platform.

Segment Results for three months ended September 30, 2026:

All comparisons are to the three months ended September 30, 2025 unless otherwise stated.

Three Months Ended September 30, 2026
(in thousands) Care Partners Care Delivery Care Enablement Intersegment Elimination Corporate Costs Consolidated Total
Total revenues $ 968,757 $ 91,017 $ 92,001 $ (128,159) $ — $ 1,023,616
% change vs. prior year quarter 8 % 5 % 5 %
Cost of services 829,490 69,116 47,915 (46,453) — 900,068
General and administrative expenses 77,694 22,229 18,425 (81,713) 31,412 68,047
Depreciation and amortization 12,480 1,263 1,226 — 653 15,622
Total expenses 919,664 92,608 67,566 (128,166) 32,065 983,737
Income (loss) from operations $ 49,093 $ (1,591) $ 24,435 $ 7 (1) $ (32,065) $ 39,879
% change vs. prior year quarter 94 % 56 % 4 %
(1) Income from operations for the intersegment elimination represents sublease income between segments. Sublease income is presented within other income, which is not presented in the table.

2026 Guidance:

Based on the Company's existing business, current view of existing market conditions, and assumptions, the Company is providing guidance for total revenue and Adjusted EBITDA for the quarter ending December 31, 2026 and narrowing guidance for total revenue, Adjusted EBITDA, and free cash flow for the year ending December 31, 2026.

Three Months Ending December 31, 2026 Year Ending December 31, 2026
Guidance Range Guidance Range
($ in millions) Low High Low High
Total revenue $ 939 $ 1,039 $ 3,900 $ 4,000
Adjusted EBITDA $ 48.5 $ 61.5 $ 261 $ 274
Free cash flow $ 107.5 $ 130

See "Guidance Reconciliation of Net Income to EBITDA and Adjusted EBITDA," "Guidance Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow," and "Use of Non-GAAP Financial Measures" below for additional information. There can be no assurance that actual amounts will not be materially higher or lower than these expectations. See "Forward-Looking Statements" below for additional information.

Conference Call and Webcast Information:

Astrana will host a conference call at 2:30 p.m. PT/5:30 p.m. ET today (Thursday, November 5**,** 2026), during which management will discuss the results of the third quarter ended September 30, 2026. To participate in the conference call, please use the following dial-in numbers about 5 minutes prior to the scheduled conference call time:

U.S. & Canada (Toll-Free):       +1 (877) 858-9810
International (Toll):                   +1 (201) 689-8517

The conference call can also be accessed via webcast at:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=PPgZy93u

An accompanying slide presentation will be available in PDF format on the "IR Calendar" page of the Company's website (https://ir.astranahealth.com/news-events/ir-calendar ) after issuance of the earnings release and will be furnished as an exhibit to Astrana's current report on Form 8-K to be filed with the SEC, accessible at www.sec.gov .

Those who are unable to attend the live conference call may access the recording at the above webcast link, which will be made available shortly after the conclusion of the call.

Note About Consolidated Entities

The Company consolidates entities in which it has a controlling financial interest. The Company consolidates subsidiaries in which it holds, directly or indirectly, more than 50% of the voting rights, and variable interest entities ("VIEs") in which the Company is the primary beneficiary. Non-controlling interests represent third party equity ownership interests in the Company's consolidated entities (including certain VIEs). The amount of net income or loss attributable to non-controlling interests is disclosed in the Company's consolidated statements of income.

About Astrana Health, Inc.

Astrana Health is a physician-centric, AI-powered healthcare company committed to delivering high-quality, patient-centered care. Built from the physician's perspective, Astrana combines its scalable care delivery infrastructure, proprietary technology platform, and aligned provider networks to enable proactive, preventive care at scale - improving patient outcomes, enhancing patient experiences, supporting provider well-being, and driving greater value across the healthcare system.

Today, Astrana supports more than 20,000 providers and approximately 1.5 million patients in value-based care arrangements through its affiliated provider networks, management services organization, and integrated care delivery clinics spanning primary, specialty, and ancillary care. Together, Astrana is building the healthcare system we all deserve - one that delivers better care, better experiences, and better outcomes for all. For more information, visit www.astranahealth.com .

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements about the Company's guidance for the quarter ending and the year ending  December 31, 2026, ability to meet operational goals, ability to meet expectations in deployment of care coordination and management capabilities, ability to decrease cost of care while improving quality and outcomes, ability to deliver sustainable revenue and EBITDA growth as well as long-term value, ability to respond to the changing environment, statements about the Company's liquidity, and successful completion and implementation of strategic growth plans, acquisition strategy, and merger integration efforts, as well as statements regarding the material weakness in internal control over financial reporting and the Company's ability to remediate such material weakness in a timely manner. Forward-looking statements reflect current views with respect to future events and financial performance and therefore cannot be guaranteed. Such statements are based on the current expectations and certain assumptions of the Company's management, and some or all of such expectations and assumptions may not materialize or may vary significantly from actual results. Actual results may also vary materially from forward-looking statements due to risks, uncertainties and other factors, known and unknown, including the risk factors described from time to time in the Company's reports to the SEC, including, without limitation the risk factors discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, and subsequent quarterly reports on Form 10-Q. Any forward-looking statement made by the Company in this release speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.

October 19, 2026 11:00am EDT Download as PDF

New collaboration expands access to multilingual, community-based care across seven Northern and Southern California counties

ORANGE, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced a provider arrangement with Astrana Health, a leading value-based care organization with deep roots in California, that will expand in-network access to primary and specialty care for Medicare Advantage beneficiaries across Southern and Northern California. Beginning Jan. 1, 2027, the collaboration will serve members in Los Angeles, Orange, Riverside, San Bernardino, San Francisco, San Mateo and Santa Clara counties.

California’s older adults are increasingly diverse, with nearly 4 in 10 speaking a language other than English at home, according to the California Department of Aging. Through its arrangement with Astrana, Alignment is expanding access to physicians rooted in the communities they serve, many of whom offer multilingual and culturally responsive care. Members across the seven-county service area will have in-network access to Astrana's network of 3,000 primary care providers and 6,500 specialists. The service area is home to more than 3.7 million people with Medicare, according to data from the Centers for Medicare & Medicaid Services as of September 2026.1

“Every senior deserves access to high-quality care that is personal, connected and delivered by providers they know and trust,” said Dawn Maroney, president of Alignment Health and CEO of Alignment Health Plan. “By partnering with Astrana, we are expanding access to trusted local physicians across more California communities while pairing that care with the coordinated support, actionable clinical insights and personalized service that help our members navigate their care and achieve better health outcomes.”

“For decades, our affiliated physicians have cared for California’s diverse communities, often in the languages their patients speak at home,” said Brandon Sim, president and CEO of Astrana Health. “This partnership with Alignment Health opens a new channel of access to those trusted local doctors across seven counties and brings our value-based care model to more Medicare Advantage members, helping prove that high-quality, high-value care can be delivered close to home.”

Care That Reflects California’s Diverse Communities

The provider arrangement will support members across multiple Alignment plans, including Central Health Harmony (HMO), Alignment’s new Medicare Advantage plan designed for Chinese-, Korean- and Vietnamese-speaking seniors in Los Angeles and Orange counties. Through Astrana-affiliated practices and other network providers, Central Health Harmony members will have access to more than 600 in-language primary care physicians.

Trusted Local Care Across California

  • Southern California: Through Astrana’s affiliated medical groups, Alignment Health is expanding access to coordinated, community-based care for Medicare beneficiaries across Southern California. These provider networks reflect the diversity of the communities they serve, offering culturally responsive care and multilingual support while meeting the needs of members who prefer care in English. Allied Pacific of California IPA, one of the largest physician networks in the San Gabriel Valley, has cared for patients since 1992, with providers offering care in English, Mandarin, Cantonese, Korean, Vietnamese and Spanish. Daehan Prospect Medical Group provides care across Orange and Los Angeles counties, with strong ties to Korean American communities, while Prospect Nuestra Familia Medical Group offers locally based care with experience supporting Hispanic communities with services available in both Spanish and English. In the Inland Empire, Alpha Care Medical Group provides another established local network for Medicare beneficiaries.

  • Northern California: Alignment is continuing to strengthen access to care in Northern California. Through its arrangements with Astrana Health and Bay Area Care Partners in Santa Clara County, as well as its relationship with All American Medical Group (AAMG) in San Francisco and San Mateo counties, Alignment is expanding access to trusted primary and specialty care providers across the area.

Medicare’s Annual Enrollment Period runs Oct. 15 through Dec. 7, with coverage taking effect Jan. 1, 2027. To learn more about Alignment Health Plan’s 2027 Medicare Advantage plans, please visit alignmenthealthplan.com or call 1-888-979-2247.2

October 09, 2026 4:05pm EDT Download as PDF

ALHAMBRA, Calif., Oct. 9, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the third quarter ended September 30, 2026, after the close of the stock market on Thursday, November 5, 2026. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

Participant Dial-in Numbers: 877-858-9810 / +1 201-689-8517

To access the call, please dial in approximately five minutes before start time. An accompanying slide presentation will be available in PDF format on the "IR Calendar" page of the Company's website (https://ir.astranahealth.com/news-events/ir-calendar

) after issuance of the earnings release.

**Webcast:

**The call will also be available via online webcast at:

Those who are unable to attend the live conference call may access the recording at the above webcast link, which will be made available shortly after the conclusion of the call.

Prompts

Astrana Health Inc. (ticker ASTH), listed in United States.

Company History

Date Change Detail
Feb 26, 2024 Renamed APOLLO MEDICAL HOLDINGS, INC. → ASTRANA HEALTH, INC.
Sep 11, 2008 Renamed SICLONE INDUSTRIES INC → APOLLO MEDICAL HOLDINGS, INC.
— Former tickers AMEH

ETFs Holding Astrana Health Inc.

ETF Weight in ETF Shares Market value As of
TCV 2.10% 130,362 $ 4.17M Nov 18, 2026
HYP 1.35% 20,143 $ 934.837K Jun 30, 2026
LITL 0.48% 849 $ 27.16K Nov 17, 2026
QIDX 0.31% 3,368 $ 119.766K Jul 31, 2026
RUSC 0.21% 3,632 $ 168.561K Jun 30, 2026
AFSM 0.13% 5,898 $ 193.867K Nov 16, 2026
PSC 0.12% 59,272 $ 2.751M Jun 30, 2026
AVSC 0.09% 82,606 $ 2.715M Nov 16, 2026
RESM 0.09% 68 $ 3,155.88 Jun 30, 2026
VFMO 0.08% 40,222 $ 1.533M Aug 31, 2026
DFAS 0.04% 373,700 $ 11.872M Nov 12, 2026
DFAT 0.03% 325,514 $ 10.342M Nov 12, 2026
DFSV 0.03% 265,912 $ 8.448M Nov 12, 2026
SMDX 0.03% 1,217 $ 40.003K Nov 17, 2026
MSSM 0.02% 2,926 $ 111.51K Aug 31, 2026
DXUV 0.01% 26,701 $ 848.291K Nov 12, 2026
EBI 0.01% 2,437 $ 92.874K Aug 31, 2026
DFAC 0.01% 155,450 $ 4.939M Nov 12, 2026
DFSU 0.01% 4,198 $ 133.37K Nov 12, 2026
DFAU 0.00% 13,787 $ 438.013K Nov 12, 2026
DCOR 0.00% 35,280 $ 1.121M Nov 12, 2026
DFUV 0.00% 10,954 $ 348.009K Nov 12, 2026
DFUS 0.00% 13,941 $ 442.906K Nov 12, 2026